Headache

Real-world data to enhance migraine clinical trials 2:22
Real-world data to enhance migraine clinical trials
Raffaele Ornello • 5 Dec 2022
Switching erenumab to fremanezumab in chronic migraine: results of a real-world study 1:49
Switching erenumab to fremanezumab in chronic migraine: results of a real-world study
Valeria Caponnetto • 14 Dec 2022
Implications of prime representation of the ICHD3 criteria 5:23
Implications of prime representation of the ICHD3 criteria
Pengfei Zhang • 9 Dec 2022
A number theory diagnostic method for primary headache disorders 1:58
A number theory diagnostic method for primary headache disorders
Pengfei Zhang • 9 Dec 2022
The link between interictal migraine brain and acute migraine symptoms 2:51
The link between interictal migraine brain and acute migraine symptoms
Roberta Messina • 13 Dec 2022
Preliminary data on the use of anti-CGRP mAbs in pediatric migraine 1:30
Preliminary data on the use of anti-CGRP mAbs in pediatric migraine
Massimiliano Valeriani • 15 Dec 2022
Real-world data on anti-CGRP monoclonal antibodies 8:29
Real-world data on anti-CGRP monoclonal antibodies
Gisela Terwindt • 12 Dec 2022
Does adenosine infusion induce migraine attacks in migraine patients? 3:40
Does adenosine infusion induce migraine attacks in migraine patients?
Janu Thuraiaiyah • 15 Dec 2022
OnabotulinumtoxinA in elderly patients with chronic migraine: real-world evidence 2:12
OnabotulinumtoxinA in elderly patients with chronic migraine: real-world evidence
Raffaele Ornello • 5 Dec 2022
Personalized treatment in migraine prevention 1:48
Personalized treatment in migraine prevention
Yi-Chieh Chen • 5 Apr 2022
Ongoing trials investigating psychedelic-assisted therapies 1:41
Ongoing trials investigating psychedelic-assisted therapies
Tadeusz Hawrot • 26 Jun 2022
A pilot study of the effect of pharmacogenomic data on dosages of verapamil for migraine prevention 4:46
A pilot study of the effect of pharmacogenomic data on dosages of verapamil for migraine prevention
Yi-Chieh Chen • 5 Apr 2022
Discontinuation and reinitiation of migraine treatment with GCRP mAbs 1:13
Discontinuation and reinitiation of migraine treatment with GCRP mAbs
Uwe Reuter • 25 Jun 2022
Lifestyle management and recommendations in headache care 6:01
Lifestyle management and recommendations in headache care
Lauren Natbony • 7 Jun 2022
The burden of migraine: from individuals to society 2:43
The burden of migraine: from individuals to society
Messoud Ashina • 23 Jun 2022
Pontine-hypothalamic interplay for predicting migraine progression 3:31
Pontine-hypothalamic interplay for predicting migraine progression
Roberta Messina • 13 Apr 2022
The content of VJNeurology is intended for healthcare professionals